Marsh McLennan (MRSH) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Achieved $24.5B in 2024 revenue, with 8% total and 7% underlying growth, marking the best growth stretch in over two decades and 17 consecutive years of margin expansion.
Adjusted operating income rose 11% to $6.2B, and adjusted EPS increased 10% to $8.80, the 4th consecutive year of 10%+ adjusted EPS growth.
2024 was the largest acquisition year, investing $9.4B, including the $7.75B McGriff acquisition, expanding middle market presence.
Raised dividend by 15% to $3.05 per share and repurchased $900M in shares.
Capital-light model generated nearly $4B in free cash flow, supporting disciplined capital management.
Financial highlights
Q4 consolidated revenue was $6.1B, up 9% (7% underlying); full-year revenue grew at an 8% CAGR from 2019–2024.
Adjusted operating margin reached 26.8% in 2024, up 80 bps from 2023 and 1,330 bps since 2010.
Free cash flow reached $4B in 2024, with a 17% CAGR since 2010 and FCF margin of 16%.
Total shareholder return since 2010 was 925%, compared to 510% for the S&P 500.
Q4 adjusted EPS was $1.87, up 11% year-over-year.
Outlook and guidance
Expect mid-single-digit underlying revenue growth in 2025, with continued margin expansion and solid adjusted EPS growth.
Anticipate headwinds from fiduciary income, FX, and discrete tax items, especially in Q1 2025.
Plan to deploy ~$4.5B in capital in 2025 across dividends, acquisitions, and share repurchases.
Adjusted effective tax rate expected between 25%-26% in 2025.
Focus remains on investing in talent, technology, and innovation to sustain competitive advantage.
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q2 revenue up 6%, EPS up 10%, margin 29%, and dividend raised 15% amid robust growth.MRSH
Q2 20243 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025